Action ADXN ADDEX THERAPEUTICS LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Addex Therapeutics Ltd

Actions

ADXN

CH0029850754

Marché Fermé - Swiss Exchange
Autres places de cotation
 17:30:33 15/07/2024 		Varia. 5j. Varia. 1 janv.
0,0636 CHF +7,43 % Graphique intraday de Addex Therapeutics Ltd -0,31 % +38,26 %
15/07 Addex Therapeutics Ltd présente les résultats positifs du programme GABAB PAM contre la toux au treizième symposium international de Londres sur la toux CI
06/06 Transcript : Addex Therapeutics Ltd, Q1 2024 Earnings Call, Jun 06, 2024

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)
GL
Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)
GL
Addex Shareholders Approve All Resolutions at Annual General Meeting
GL
ADDEX THERAPEUTICS : INDEX TO UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Form 6 K
PU
Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update
GL
Addex Convenes Annual General Meeting 2024
GL
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GL
Addex to Present at Bio€quity Europe 2024
GL
Addex Provides Update on ADX71149 Phase 2 Epilepsy Study
GL
Addex to Present at the Swiss Biotech Day 2024
GL
Addex to Present at the Swiss Biotech Day 2024
AQ
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
GL
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
AQ
Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024
GL
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders
GL
Addex to Present at the Bio-Europe Spring 2024 Conference
GL
Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.
GL
Addex to Present at the Swiss Equities Baader Conference
GL
Addex to Present at the Swiss Equities Baader Conference
AQ
Addex to Present at the Swiss Equities Baader Conference
DJ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ADXN
  4. Actualités Addex Therapeutics Ltd
  5. Communiqués